© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 60660 refers to the procedure of ablating one or more thyroid nodule(s) located in either one lobe of the thyroid gland or the isthmus. This procedure is performed percutaneously, meaning it is done through the skin, and it includes the use of imaging guidance, specifically ultrasound, to ensure accurate targeting of the nodule(s). The primary goal of this minimally invasive technique is to alleviate symptoms such as dysphagia, which is difficulty swallowing, that may arise from benign enlargement of thyroid tissue. During the procedure, a local anesthetic is administered to minimize discomfort, and a specialized radiofrequency ablation probe is inserted into the nodule. The probe emits radio waves that generate heat, effectively destroying the cells within the nodule and leading to its reduction in size as it transforms into scar tissue. Continuous ultrasound guidance is utilized throughout the procedure to monitor the treatment area and ensure that the ablation is performed accurately, while also protecting surrounding healthy tissue. A small margin of healthy tissue is intentionally left untreated to prevent damage to adjacent structures. This procedure is reported using CPT® Code 60660 for the initial lobe or isthmus treated, with additional nodules in the second lobe being reported under CPT® Code 60661.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.